Genoil (GNOLF) Operating Expenses (2009 - 2025)

Genoil (GNOLF) has reported Operating Expenses for 16 consecutive years, with $117630.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Operating Expenses fell 92.41% year-over-year to $117630.0 in Q4 2025; TTM through Dec 2025 was $626092.0, a 68.83% decrease from a year earlier, with the FY2025 full-year figure at $626092.0, down 68.83% from the prior year.
• Operating Expenses was $117630.0 for Q4 2025 at Genoil, down from $147005.0 in the prior quarter.
• Over five years, Operating Expenses peaked at $2.2 million in Q1 2023 and troughed at $104359.0 in Q4 2021.
• A 5-year average of $458884.2 and a median of $159431.0 in 2021 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses plunged 96.33% in 2021 and surged 711.64% in 2023, its largest moves.
• Over 5 years, Operating Expenses stood at $104359.0 in 2021, then soared by 36.84% to $142801.0 in 2022, then soared by 711.64% to $1.2 million in 2023, then soared by 33.71% to $1.5 million in 2024, then plunged by 92.41% to $117630.0 in 2025.
• The last three Operating Expenses figures came in at $117630.0 (Q4 2025), $147005.0 (Q3 2025), and $213951.0 (Q2 2025), per Business Quant data.